FLGT Fulgent Genetics Inc

Fulgent Genetics Inc is a technology company offering genetic testing to provide physicians with clinically actionable diagnostic information used to improve the overall quality of patient care.

$81.83  -1.72 (-2.06%)
As of 12/03/2021 15:59:58 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  09/29/2016
Outstanding shares:  29,831,451
Average volume:  580,665
Market cap:   $2,492,417,731
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    359664109
ISIN:        US3596641098
Sedol:      BYQBFQ5
Valuation   (See tab for details)
PE ratio:   4.29
PB ratio:   2.35
PS ratio:   2.41
Return on equity:   54.91%
Net income %:   54.96%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy